Literature DB >> 9186356

Botulinum toxin: novel treatment for dramatic urethral dilatation associated with dysfunctional voiding.

G F Steinhardt1, S Naseer, O A Cruz.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9186356     DOI： 10.1097/00005392-199707000-00067

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  10 in total

1.  Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study.

Authors:  Po-Ming Chow; Sheng-Mou Hsiao; Hann-Chorng Kuo
Journal:  Int Urogynecol J       Date:  2020-06-18       Impact factor: 2.894

Review 2.  Dysfunctional Voiders-Medication Versus Urotherapy?

Authors:  Angela M Arlen
Journal:  Curr Urol Rep       Date:  2017-02       Impact factor: 3.092

Review 3.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

4.  An infantile case of Hinman syndrome with severe acute renal failure.

Authors:  Vorapong Chaichanamongkol; Masahiro Ikeda; Kenji Ishikura; Yuko Hamasaki; Hiroshi Hataya; Hiroyuki Satoh; Hiroshi Asanuma; Seiichiro Shishido; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2008-04-15       Impact factor: 2.801

5.  Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the International Children's Continence Society.

Authors:  Stephen Yang; Michael E Chua; Stuart Bauer; Anne Wright; Per Brandström; Piet Hoebeke; Søren Rittig; Mario De Gennaro; Elizabeth Jackson; Eliane Fonseca; Anka Nieuwhof-Leppink; Paul Austin
Journal:  Pediatr Nephrol       Date:  2017-10-03       Impact factor: 3.714

Review 6.  Pediatric overactive bladder syndrome: pathophysiology and management.

Authors:  Israel Franco
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 7.  Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction.

Authors:  Hann-Chorng Kuo
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-08-28

Review 8.  The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.

Authors:  Yao-Lin Kao; Kuan-Hsun Huang; Hann-Chorng Kuo; Yin-Chien Ou
Journal:  Toxins (Basel)       Date:  2019-12-13       Impact factor: 4.546

9.  Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience.

Authors:  N K Mohanty; Rajiba L Nayak; Mohd Alam; R P Arora
Journal:  Indian J Urol       Date:  2008-04

10.  OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction - A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Yuan-Hong Jiang; Chung-Cheng Wang; Hann-Chorng Kuo
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.